| November 2 |
Byetta (exenatide) - Altered kidney function, including acute renal failure/renal insufficiency, in patients on Byetta |
| November 2 |
Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's Byetta (Exenatide) Injection Update |
| November 3 |
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth |
| November 3 |
Connecticut Attorney General Writes Seasonal Flu Vaccine Makers, Distributors Regarding Alleged Price Gouging, Preferential Treatment |
| November 4 |
New Merck Begins Operations Worldwide |
| November 4 |
New Merck Begins Operations |
| November 4 |
Nation?s Largest Nursing Home Pharmacy and Drug Manufacturer to Pay $112 Million to Settle False Claims Act Cases |
| November 5 |
Sermo Launches the Practice Management Exchange to Support the New Physician Practice in a Changing Healthcare World |
| November 5 |
Genmab Reorganizes to Build Sustainable Business |
| November 5 |
Genmab Revises Financial Guidance |
| November 5 |
IMS Health to be Acquired by TPG and CPP Investment Board |
| November 5 |
IMS Health to be Acquired by TPG and CPP Investment Board |
| November 6 |
Theravance and Astellas Announce the Commercial Launch of Vibativ (telavancin) in the United States |
| November 6 |
Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences |
| November 9 |
PhRMA Statement on House Passage of Health Care Reform Bill |
| November 9 |
Computerized Support Keeps Prominence of Name Brand Drugs at Bay |
| November 9 |
Covidien Submits Label Change for Optimark Contrast Agent |
| November 9 |
Monsanto to Purchase Chesterfield Village Research Center From Pfizer |
| November 10 |
Hospira Brand Propofol and Liposyn Products - Recall:Product containers may contain particulate matter that could act as emboli and lead to impeded blood flow |
| November 10 |
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic |
| November 10 |
PhRMA Statement About Accessing Online Health Information |
| November 10 |
Basketball Legend Kareem Abdul-Jabbar Announces He Has Been Diagnosed With Chronic Myeloid Leukemia; Aims To Inspire Others |
| November 12 |
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain |
| November 12 |
Despite Some Benefit, Drug Ads Can Be Harmful to Your Health |
| November 12 |
Action on Antipsychotic Drugs and Dementia |
| November 12 |
New Web Sites Educate About Triglycerides and HDL Cholesterol |
| November 13 |
Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline |
| November 13 |
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies |
| November 13 |
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor |
| November 13 |
Drug Companies to Fight Neglected Diseases |
| November 13 |
Eli Lilly Hires Paul as Chief Researcher |
| November 13 |
Google Helps You Find A Flu Shot |
| November 13 |
Cephalon, Barr Settle Fentora Dispute |
| November 13 |
Google, Yahoo Call for Expanded Online Drug Ads |
| November 13 |
Swiss OK Novartis Swine Flu Vaccine From Cells |
| November 13 |
FDA Finds Bits of Steel, Rubber in Genzyme Drugs |
| November 14 |
Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care |
| November 14 |
Genzyme Issues Letters to U.S. Healthcare Providers |
| November 16 |
Bristol-Myers Squibb Announces Split-Off of Mead Johnson |
| November 16 |
FDA Sends Warning Letters for Dacogen and Fosrenol |
| November 16 |
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release) |
| November 16 |
Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme |
| November 16 |
Study Raises New Questions About Merck Pill Zetia |
| November 16 |
Sanofi-Aventis Swine Flu Vaccine Cleared in France |
| November 16 |
GlaxoSmithKline, Nabi to Develop Smoking Vaccine |
| November 16 |
Boehringer Ingelheim Developing 'Female Viagra' |
| November 16 |
Lilly's Big Cancer Bet: Seeking New Blockbusters |
| November 16 |
Drug Industry Raises Prices by 9% |
| November 16 |
Merck Announces Completion of Patient Enrollment in Phase III TRA-2°P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor |
| November 17 |
Novartis: Lower Dose of Flu Vaccine Sufficient (AP) |
| November 17 |
FDA Says Prilosec Can Block Benefits of Plavix |
| November 17 |
Novartis: Lower Dose of Flu Vaccine Sufficient |
| November 17 |
FDA Reviews Update to Pfizer Vaccine for Kids |
| November 17 |
Genzyme Flops at FDA: Allston Plant Problems Delay Drug Review [Boston Herald] |
| November 17 |
Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease, Stanford Researcher Finds |
| November 17 |
Common Cold Virus May Have Foiled HIV Vaccine Test |
| November 17 |
FDA and Everyday Health Collaborate to Expand Reach of Consumer Health Information |
| November 18 |
FDA Says Heartburn Drugs Can Interfere with Plavix |
| November 18 |
Vaccines on Horizon for AIDS, Alzheimer's, Herpes |
| November 18 |
Pfizer Inc Submits New Pediatric Data for Lipitor to EMEA |
| November 18 |
FDA Approves New Post-Shingles Attack Drug |
| November 18 |
Pfizer Enters Tropical Disease Drug Partnership |
| November 18 |
InterMune Shares Fall on Change in Hepatitis Study |
| November 18 |
Ex-Pharma Executive Runs as Dem for Kansas Governor |
| November 19 |
Genentech, Biogen Get FDA Request on Rituxan |
| November 19 |
AstraZeneca Seeks Brilinta Approval in US |
| November 19 |
FDA Panel Backs Pfizer's Enhanced Vaccine for Kids |
| November 19 |
Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price Increases |
| November 19 |
Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate |
| November 19 |
PhRMA Statement on Misleading Reports About Price Growth |
| November 19 |
FDA Issues 22 Warning Letters to Web Site Operators |
| November 19 |
WHO: Swine Flu Shot Not Causing Deaths |
| November 19 |
FDA Panel Backs Safety, Benefits of Spiriva |
| November 20 |
Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star] |
| November 20 |
Moody's Gives Negative View on Pharma Credit |
| November 20 |
The Botax? Nip/Tuck Levy to Help Health Care Plan |
| November 20 |
Antitrust Lawyer Files Suit to Stop Pfizer Merger |
| November 20 |
Saatchi & Saatchi Wellness Names Russell as Managing Director |
